Paradoxical activation of the protein kinase-transcription factor ERK5 by ERK5 kinase inhibitors (2020)
Attributed to:
Defining the role of ERK5 kinase and ERK5 transcriptional activities in cell migration and EMT using novel ERK5 inhibitors
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-020-15031-3
PubMed Identifier: 32170057
Publication URI: http://europepmc.org/abstract/MED/32170057
Type: Journal Article/Review
Parent Publication: Nature Communications
Issue: 1
ISSN: 2041-1723